Suchergebnisse - (Person:"Cinatl, Jindrich")

PubPharm (5)

1

ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance

enthalten in: Oncotarget | 2016

von Löschmann, N. | Michaelis, M. | Rothweiler, F. | +4

2

Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status

enthalten in: Oncotarget | 2015

von Michaelis, M. | Rothweiler, F. | Löschmann, N. | +3

3

Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression

enthalten in: BMC research notes | 2014

von Michaelis, M. | Rothweiler, F. | Nerreter, T. | +5

4

Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 function

enthalten in: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques | 2014

von Michaelis, M. | Rothweiler, F. | Nerreter, T. | +5

5

Aurora kinases as targets in drug-resistant neuroblastoma cells

enthalten in: PloS one | 2014

von Michaelis, M. | Selt, F. | Rothweiler, F. | +5

1
[1]